Logo image of CJR-B.CA

CORUS ENTERTAINMENT INC-B SH (CJR-B.CA) Stock Fundamental Analysis

TSX:CJR-B - Toronto Stock Exchange - CA2208741017 - Common Stock - Currency: CAD

0.095  0 (0%)

Fundamental Rating

3

Taking everything into account, CJR-B scores 3 out of 10 in our fundamental rating. CJR-B was compared to 11 industry peers in the Media industry. There are concerns on the financial health of CJR-B while its profitability can be described as average. CJR-B has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CJR-B has reported negative net income.
In the past year CJR-B had a positive cash flow from operations.
In the past 5 years CJR-B reported 4 times negative net income.
In the past 5 years CJR-B always reported a positive cash flow from operatings.
CJR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCJR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -51.23%, CJR-B is doing worse than 72.73% of the companies in the same industry.
With an excellent Return On Invested Capital value of 9.71%, CJR-B belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CJR-B is in line with the industry average of 7.53%.
The last Return On Invested Capital (9.71%) for CJR-B is above the 3 year average (8.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -51.23%
ROE N/A
ROIC 9.71%
ROA(3y)-24.86%
ROA(5y)-17.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.4%
ROIC(5y)7.93%
CJR-B.CA Yearly ROA, ROE, ROICCJR-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

CJR-B has a Operating Margin of 11.10%. This is in the better half of the industry: CJR-B outperforms 72.73% of its industry peers.
CJR-B's Operating Margin has declined in the last couple of years.
CJR-B has a better Gross Margin (56.52%) than 81.82% of its industry peers.
CJR-B's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.1%
PM (TTM) N/A
GM 56.52%
OM growth 3Y-17.74%
OM growth 5Y-11.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.57%
GM growth 5Y-2.57%
CJR-B.CA Yearly Profit, Operating, Gross MarginsCJR-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

2

2. Health

2.1 Basic Checks

CJR-B has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CJR-B has about the same amount of shares outstanding.
Compared to 5 years ago, CJR-B has less shares outstanding
Compared to 1 year ago, CJR-B has a worse debt to assets ratio.
CJR-B.CA Yearly Shares OutstandingCJR-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CJR-B.CA Yearly Total Debt VS Total AssetsCJR-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CJR-B has an Altman-Z score of -1.50. This is a bad value and indicates that CJR-B is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.50, CJR-B is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
The Debt to FCF ratio of CJR-B is 15.36, which is on the high side as it means it would take CJR-B, 15.36 years of fcf income to pay off all of its debts.
CJR-B has a Debt to FCF ratio (15.36) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 15.36
Altman-Z -1.5
ROIC/WACC2.35
WACC4.13%
CJR-B.CA Yearly LT Debt VS Equity VS FCFCJR-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

CJR-B has a Current Ratio of 0.80. This is a bad value and indicates that CJR-B is not financially healthy enough and could expect problems in meeting its short term obligations.
CJR-B has a worse Current ratio (0.80) than 72.73% of its industry peers.
A Quick Ratio of 0.80 indicates that CJR-B may have some problems paying its short term obligations.
With a Quick ratio value of 0.80, CJR-B is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
CJR-B.CA Yearly Current Assets VS Current LiabilitesCJR-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2

3. Growth

3.1 Past

The earnings per share for CJR-B have decreased strongly by -105.56% in the last year.
The earnings per share for CJR-B have been decreasing by -43.12% on average. This is quite bad
The Revenue for CJR-B has decreased by -15.32% in the past year. This is quite bad
CJR-B shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.52% yearly.
EPS 1Y (TTM)-105.56%
EPS 3Y-61.41%
EPS 5Y-43.12%
EPS Q2Q%-30%
Revenue 1Y (TTM)-15.32%
Revenue growth 3Y-6.28%
Revenue growth 5Y-5.52%
Sales Q2Q%-11.55%

3.2 Future

CJR-B is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.12% yearly.
CJR-B is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.14% yearly.
EPS Next Y-257.94%
EPS Next 2Y-124.08%
EPS Next 3Y18.12%
EPS Next 5YN/A
Revenue Next Year-11.02%
Revenue Next 2Y-8.02%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CJR-B.CA Yearly Revenue VS EstimatesCJR-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CJR-B.CA Yearly EPS VS EstimatesCJR-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

CJR-B reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CJR-B. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CJR-B.CA Price Earnings VS Forward Price EarningsCJR-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CJR-B indicates a rather cheap valuation: CJR-B is cheaper than 90.91% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CJR-B is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.27
EV/EBITDA 1.37
CJR-B.CA Per share dataCJR-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

A more expensive valuation may be justified as CJR-B's earnings are expected to grow with 18.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-124.08%
EPS Next 3Y18.12%

0

5. Dividend

5.1 Amount

No dividends for CJR-B!.
Industry RankSector Rank
Dividend Yield N/A

CORUS ENTERTAINMENT INC-B SH

TSX:CJR-B (2/11/2025, 7:00:00 PM)

0.095

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)01-10 2025-01-10/bmo
Earnings (Next)N/A N/A
Inst Owners5.31%
Inst Owner ChangeN/A
Ins Owners3.52%
Ins Owner ChangeN/A
Market Cap18.63M
Analysts43.08
Price Target0.09 (-5.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)52.35%
Min EPS beat(2)33.26%
Max EPS beat(2)71.44%
EPS beat(4)2
Avg EPS beat(4)-39.05%
Min EPS beat(4)-251.7%
Max EPS beat(4)71.44%
EPS beat(8)5
Avg EPS beat(8)-1%
EPS beat(12)5
Avg EPS beat(12)-165.39%
EPS beat(16)9
Avg EPS beat(16)-120.37%
Revenue beat(2)0
Avg Revenue beat(2)-5.73%
Min Revenue beat(2)-7.81%
Max Revenue beat(2)-3.66%
Revenue beat(4)0
Avg Revenue beat(4)-5.71%
Min Revenue beat(4)-7.81%
Max Revenue beat(4)-3.66%
Revenue beat(8)0
Avg Revenue beat(8)-4.37%
Revenue beat(12)1
Avg Revenue beat(12)-3.76%
Revenue beat(16)1
Avg Revenue beat(16)-3.22%
PT rev (1m)0%
PT rev (3m)-32.91%
EPS NQ rev (1m)-132%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-78.88%
EPS NY rev (3m)-78.88%
Revenue NQ rev (1m)-0.2%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)0.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF 0.27
P/OCF 0.21
P/B N/A
P/tB N/A
EV/EBITDA 1.37
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)0.36
FCFY377.26%
OCF(TTM)0.45
OCFY477.14%
SpS6.26
BVpS-2.3
TBVpS-6.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.23%
ROE N/A
ROCE 13.48%
ROIC 9.71%
ROICexc 10.63%
ROICexgc 71.12%
OM 11.1%
PM (TTM) N/A
GM 56.52%
FCFM 5.72%
ROA(3y)-24.86%
ROA(5y)-17.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.4%
ROIC(5y)7.93%
ROICexc(3y)8.88%
ROICexc(5y)8.26%
ROICexgc(3y)101.91%
ROICexgc(5y)97.84%
ROCE(3y)11.67%
ROCE(5y)11.02%
ROICexcg growth 3Y19.08%
ROICexcg growth 5Y5.54%
ROICexc growth 3Y19.25%
ROICexc growth 5Y13.77%
OM growth 3Y-17.74%
OM growth 5Y-11.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.57%
GM growth 5Y-2.57%
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 15.36
Debt/EBITDA 1.46
Cap/Depr 3.1%
Cap/Sales 1.52%
Interest Coverage 2.07
Cash Conversion 12.07%
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z -1.5
F-Score5
WACC4.13%
ROIC/WACC2.35
Cap/Depr(3y)2.34%
Cap/Depr(5y)2.46%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-105.56%
EPS 3Y-61.41%
EPS 5Y-43.12%
EPS Q2Q%-30%
EPS Next Y-257.94%
EPS Next 2Y-124.08%
EPS Next 3Y18.12%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.32%
Revenue growth 3Y-6.28%
Revenue growth 5Y-5.52%
Sales Q2Q%-11.55%
Revenue Next Year-11.02%
Revenue Next 2Y-8.02%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A
EBIT growth 1Y-25.27%
EBIT growth 3Y-22.91%
EBIT growth 5Y-16.24%
EBIT Next Year21.15%
EBIT Next 3Y11.2%
EBIT Next 5YN/A
FCF growth 1Y-61.78%
FCF growth 3Y-23.78%
FCF growth 5Y-18.48%
OCF growth 1Y-56.16%
OCF growth 3Y-21.92%
OCF growth 5Y-17.58%